Barclays
BSTG

Barclays’s Biostage, Inc. Common Stock BSTG Stock Holding History

Barclays’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,846
Closed -$15K – 7805
2014
Q3 		$15K Sell
1,846
-3,985
-68% -$32.6K ﹤0.01% 6677
2014
Q2 		$58K Buy
5,831
+3,161
+118% +$26.9K ﹤0.01% 5834
2014
Q1 		$24K Buy
2,670
+1,394
+109% +$8.26K ﹤0.01% 6505
2013
Q4 		$6K Buy
+1,276
New +$5.97K ﹤0.01% 7156

Other funds holding BSTG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barclays's BSTG Position: Q4 2014 in Review

Barclays sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2014, closing a stake of 1,846 shares — an estimated $15K sold.

Barclays first reported a position in BSTG in Q4 2013 and held it in 4 quarters. The position peaked at $58K in Q2 2014. 44 funds tracked by Wall St. Rank hold BSTG as of Q4 2014.

  • Barclays reported no remaining Biostage, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Barclays sold 1,846 Biostage, Inc. Common Stock shares in Q4 2014, an estimated $15K.
  • Barclays first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 4 quarters.
  • Barclays's Biostage, Inc. Common Stock position peaked at $58K in Q2 2014.
  • 44 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2014.

Based on Barclays's 13F filing for Q4 2014, filed 13 Feb 2015.